Tenon Medical, Inc. (TNON)
NASDAQ:TNON
Want to see TNON full AI Analyst Report?
Earnings Data
Report Date
Aug 12, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.24Last Year’s EPS
-0.36Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed clear progress: strong Q1 revenue (~+90% YoY), record gross profit and a large margin expansion (+24 percentage points), tangible commercial and IP investments, and added financing that extends runway. The company still operates at a net loss with OpEx elevated relative to a small revenue base and relies on successful commercial conversion and upcoming product launches to sustain momentum. Overall, the positives (sharp growth, margin gains, funding, IP and training investments) outweigh the risks, though meaningful execution is required to translate momentum into sustained profitability.Company Guidance
Record First-Quarter Revenue Growth
Revenue for Q1 2026 was $1.4 million, nearly double the prior-year quarter (~90% YoY increase from $0.7M). Growth drivers were higher procedure volumes for Catamaran and the first full quarter of Symmetry Plus contribution after the SciVantage asset acquisition.
Historic Gross Profit and Margin Expansion
Gross profit rose to $0.9 million (68.5% gross margin) versus $0.3 million (44.5%) in Q1 2025 — an approximate +193% increase in dollar gross profit and a ~24 percentage-point margin expansion year over year. Management expects continued margin expansion with scale (targeting 70%+ at larger revenue bases).
Improved Profitability Trend (Narrower Net Loss)
Net loss narrowed to $3.5 million (loss per share $0.31) from $3.6 million (loss per share $1.01) a year ago. Dollar loss improvement reflects stronger revenue and gross profit; per-share improvement was materially aided by a larger share count.
Strengthened Balance Sheet and Liquidity Actions
Ended the quarter with $4.6 million in cash vs. $3.8 million at 12/31/2025 (cash up ~21%). In March 2026 the company closed a private placement of senior convertible notes for gross proceeds of $4.3 million to extend runway and fund commercial/clinical priorities.
Commercial Execution and Training Momentum
Trained 21 physicians across both systems during the quarter. Company opened an equipped training and education center in Tampa, FL and added an experienced senior sales hire for the eastern U.S. to accelerate physician and distributor education.
Product Portfolio Expansion and Pipeline Catalysts
Integration of Symmetry Plus is driving revenue; the company plans incremental Symmetry Plus launches (corticator tech and an additional implant) during 2026 and a third approach alpha in Q4 2026 with a full commercial launch targeted for early 2027 — providing multiple near-term catalysts.
Intellectual Property Build-Out
Patent portfolio expanded to 29 U.S. patents and 9 international patents granted, with another 31 applications pending and multiple notices of allowance expected to grant later in 2026, strengthening differentiation and competitive protection.
Operational Efficiency and Scalable Cost Structure
Management cites a more streamlined commercial footprint and stronger field productivity that together with higher revenue have driven improved absorption of fixed production overhead; OpEx baseline (~$4.2M) is viewed as manageable with anticipated leverage as revenue scales.
TNON Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TNON Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2026 | $0.81 | $0.72 | -11.55% |
Mar 19, 2026 | $0.83 | $0.80 | -3.95% |
Nov 13, 2025 | $1.18 | $1.18 | 0.00% |
Aug 13, 2025 | $1.67 | $1.40 | -16.17% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Tenon Medical, Inc. (TNON) report earnings?
Tenon Medical, Inc. (TNON) is schdueled to report earning on Aug 12, 2026, After Close (Confirmed).
What is Tenon Medical, Inc. (TNON) earnings time?
Tenon Medical, Inc. (TNON) earnings time is at Aug 12, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TNON EPS forecast?
TNON EPS forecast for the fiscal quarter 2026 (Q2) is -0.24.